1492-1493 / 2953
Cervical IMRT
• 45-50.4Gy/25-28# with concurrent chemo
• Dosimetric benefits
• Small bowel (V45 halved)
• Bladder volume (V45 halved)
• Rectal volume (V45↓7 fold)
• Pelvic bone dose
Roeske, Radiother Oncol 2003;69:201, Portelance IJROBP 2001;51:261